From: Risk factors for post-ERCP cholecystitis: a single-center retrospective study
Variable | Acute Cholecystitis | Statistic | P | |
---|---|---|---|---|
No (n = 2636) | Yes (n = 36) | |||
Age (y), Mean ± SD | 62.4 ± 16.28 | 62.2 ± 12.90 | t = 0.097 | 0.923 |
Female | 1145 (43.4%) | 21 (58.3%) | x2 = 2.627 | 0.105 |
Past history | ||||
Hypertension | 976 (37.0%) | 13 (36.1%) | x2 = 0.013 | 0.910 |
Hyperlipemia | 70 (2.7%) | 1 (2.9%) | x2 = 0.005 | 0.942 |
Diabetes mellitus | 473 (18.0%) | 7 (20.0%) | x2 = 0.098 | 0.755 |
Acute pancreatitis | 459 (17.4%) | 16 (44.4%) | x2 = 17.754 | < 0.001 |
Acute cholangitis | 532 (20.2%) | 6 (16.7%) | x2 = 0.273 | 0.601 |
Chronic cholecystitis | 1427 (54.1%) | 33 (91.7%) | x2 = 20.185 | < 0.001 |
Antibiotics before ERCP | 948 (36.0%) | 11 (30.6%) | x2 = 0.451 | 0.601 |
Gallbladder opacification | 1016 (38.5%) | 24 (66.7%) | x2 = 11.816 | 0.001 |
Diameter of CBD(cm) | 1.2 ± 0.48 | 1.1 ± 0.42 | t = 1.237 | 0.216 |
Temperature before ERCP (°C) | 36.6 ± 0.58 | 36.8 ± 0.84 | t = −1.891 | 0.059 |
Bile duct stents | x2 = 15.805 | 0.001 | ||
No stent | 1174 (66.2%) | 19 (52.8%) | ||
Metallic stent | 414 (15.7%) | 14 (38.9%) | ||
Plastic stent | 436 (16.5%) | 2 (5.6%) | ||
Metallic+plastic stent | 42 (1.6%) | 1 (2.8%) | ||
Laboratory index before ERCP (Median,P25,P75) | ||||
ALT | 83.0 (37.3, 193.3) | 58.7 (37.5, 191.0) | Z = −0.027 | 0.979 |
AST | 54.9 (27.9, 119.0) | 53.5 (28.7, 83.8) | Z = −0.143 | 0.886 |
AKP | 198.1 (114.9, 359.8) | 196.3 (94.2, 321.2) | Z = −0.414 | 0.679 |
GGT | 292.5 (125.7, 550.2) | 246.9 (91.9, 543.8) | Z = −0.181 | 0.856 |
TB | 34.9 (15.5, 126.8) | 23.7 (13.7, 83.3) | Z = −0.845 | 0.391 |
DB | 21.2 (6.7, 98.8) | 12.8 (7.1, 73.4) | Z = −0.641 | 0.522 |
WBC | 6.1 (4.8, 8.2) | 7.9 (5.9, 11.0) | Z = −3.610 | < 0.001 |
Hemoglobin | 125.0 (111.0, 136.0) | 131.0 (121.0, 138.0) | Z = −1.413 | 0.158 |
Platelet count | 192.0 (148.0, 245.0) | 192.0 (146.0, 276.0) | Z = −0.210 | 0.833 |